logo-loader
viewEXMceuticals

EXMceuticals appoints cannabis expert as strategic advisor

EXM said Tripp Keber will assist with the development of its overall strategy

EXMceuticals -

Medical cannabis firm EXMceuticals Inc (CSE:EXM) has appointed the former chief executive and co-founder of Dixie Brands to its board as a strategic advisor.

Tripp Keber, who has started the role effective immediately, brings more than a decade of experience working within cannabis and hemp industries.

As well as co-founding Dixie Brands – a premium cannabis-infused products company – Keber has previously served as a director for the National Cannabis Industry Association, the Marijuana Policy Project and the National Association of Cannabis Businesses.

READ: Medical cannabis firm EXMceuticals considers future London listing as it nears first revenue

“Tripp is widely considered one of the most prominent and well-known business leaders in the cannabis industry and is recognized as an established branding expert in the medical cannabis spaces. We are thrilled to announce he will be joining the EXM team,” said Jonathan Summers, chairman of EXM.

“In his role as strategic advisor to the board, Tripp will assist with the development of EXM’s overall strategy, help to grow our strong R&D activities, contribute to cultivate relationships to enhance our market footprint, the development of EXM’s products, as well as co-ordinate our go-to market strategy."

Summers added: "Tripp already has a strong track record of actually delivering results and should set EXM apart from the significant number of CPG companies that are trying to build CBD businesses and wellness brands; whereas."

Quick facts: EXMceuticals

Price: 0.75 CAD

CSE:EXM
Market: CSE
Market Cap: $29.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

EXMceuticals secures critical R&D license for its Portugal cannabis facilities

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Andrew Scott following the news they've obtained a licence for cannabis research and development from the Portuguese government. The license was granted by INFARMED - the Portuguese National Authority of Medicines and...

on 30/10/19

2 min read